Browse press releases

The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.

8,628 resultsPage 83 of 500, newest first
  1. FinanceChangzhou Microintelligence Co., Ltd passes HKEX Listing Committee hearingHong Kong, Oct 12, 2026 - Changzhou Microintelligence Co., Ltd (“Microintelligence” or “the Company”) recently passed the hearing of the Listing Committee of The Stock Exchange of Hong Kong Limited (HKEX) on X 2026. Orient Capital, the subsidiary of Orient Securities, is the sole sponsor for the initial public offering. Based on 2025 revenue, the Company is China’s largest supplier of Embodied Industrial Intelligent Robots (EIIR), with a market share of approximately 20.0%. Microintelligence was founded in 2018. As a leader in industrial embodied intelligence, the Company develops EIIR products and integrated solutions capable of autonomous perception, learning, decision-making and executing of complex tasks with its full-stack self-developed software, hardware and systems engineering capabilities. Its products have achieved commercialization at scale in real-world industrial settings, including in industries with extremely high requirements for precision, stability, and reliability, such as 3C electronics, automotive manufacturing, new energy, fast-moving consumer goods (FMCG), and semiconductors. Meanwhile, its application scenarios are evolving from "mature single-process workflow” to "integrated workstations." According to IDC's China Industrial Embodied Intelligent Robots Market Share, 2025 report, the company holds the No. 1 market share in China. The Company is also one of the world’s first leading companies to achieve commercial verification of embodied industrial intelligence robots in multiple complex industrial scenarios. Through a standardized "Cloud-Edge-Device" integrated architecture, Microintelligence combines AI models, industrial know-how, and real-world scenario data to build core physical AI capabilities. This enables EIIR to complete a fully autonomous closed loop spanning perception, learning, decision-making, and execution. As EIIR systems roll out across real factory environments, the company has also built a "data-model-product-redeployment" flywheel. On-site data accumulated during production line operations is distilled into process knowledge through a "human-in-the-loop" mechanism with insights fed back into ongoing model iteration. As model capabilities advance, the products can take on more complex production tasks and continue to broaden their application scope. Backed by full-stack software and hardware capabilities and commercial validation in real-world scenarios, the company has delivered efficient, cost-effective commercialisation across multiple industrial scenarios, creating a durable competitive moat. Through the continuous deployment of the aforementioned technologies and industrial practices, the Company has been accumulating real production-line industrial data while maintaining high levels of R&D investment. According to the documents disclosed after its hearing, the Company amassed an unstructured, finely-annotated database sourced from real industrial scenarios, with a data volume exceeding 23TB and containing over 1.6 billion annotated data records. The database holds more than 800 independent intellectual property rights, including over 210 invention patents and 310 software copyrights. In 2024, the Company’s R&D project entitled “Development and Application of High-Speed, Self-Planning, Integrated Intelligent System for Defect Detection and Repair” has been jointly certified by the Ministry of Industry and Information Technology (MIIT) and the Ministry of Science and Technology (MOST) as having reached an “International Leading” level. The Company’s client base includes more than 25 Fortune Global 500 enterprises and leading manufacturers. Its business spans mainland China, Europe and the United States, and actively develops for the expansion into new overseas markets including Japan, Singapore and Malaysia. Financially, the Company’s revenue rose from RMB 434 million in 2023 to RMB 796 million in 2025, representing a compound annual growth rate (CAGR) of 35.4%. For the five months ended May 31, 2026, the Company recorded revenue of RMB 424 million, up 22.6% year on year. Revenue from its flagship EIIR products grew from RMB 114 million in 2023 to RMB 453 million in 2025, and reached RMB 260 million for the five months ended May 31, 2026. The EIIR products’ contribution to total revenue rose to 61.4% for the five months ended May 31, 2026, while gross margin further improved to 54.8%. In terms of profitability, the Company achieved profitable results for two consecutive years in 2024 and 2025. It recorded a full-year profit of approximately RMB 15.7 million in 2024 and approximately RMB 5.1 million in 2025, as higher R&D investment weighed on profit for the year. For the five months ended May 31, 2026, profit reached RMB 22.53 million, while adjusted net profit for the period—excluding the impact of share-based payments and listing expenses—amounted to RMB 33.84 million, up 41.5% year on year. In addition, following the turnaround to positive operating cash flow in 2025, the Company continued to record net cash inflow for the five months ended May 31, 2026, reflecting a substantive and sustained improvement in the cash-generating capability of its core business. The Company plans to primarily allocate the proceeds from this initial public offering to core technology R&D, focusing on iterating the Company’s end-to-end industrial VLA model, to continuously enhance the intelligence and performance of EIIR robots. In parallel, the Company will build localised overseas sales and service networks to deepenits global business footprint. In addition, the Company will allocate the proceeds for strategic investments and to foster an open, win-win application ecosystem through M&A, to expand manufacturing capacity to meet the growing order volumes. Looking ahead, Microintelligence will seize the opportunity presented by its HKEX listing to continue to strengthen its core capabilities in industrial embodied intelligence. As the global manufacturing sector continues to advance its intelligent transformation, the Company will focus on six key dimensions—deepening customer engagement, replicating success across new industries, expanding overseas, upgrading product value, strengthening software-hardware synergies, and driving continuous AI evolution—to bring EIIR solutions into more industrial scenarios. Together with industry partners, the Company will build an industrial embodied intelligence ecosystem and create long-term value for customers and the industry as a whole.
  2. Finance中金首予现代牙科(03600.HK)“跑赢行业”评级 目标价10.0港元:数字化赋能效率提升 加速全球扩张香港, 2026年10月12日 - (亚太商讯) - 中金首予现代牙科集团(03600.HK)“跑赢行业”评级,目标价10.00港元,并指出三大关键驱动因素:1) 数字化驱动行业整合:口内扫描技术支援标准化病例可跨区域集中处理,从而提高周转速度与效率;2025年全球义齿加工市场规模约为243亿美元,且CR3(行业前三名市场份额)仅为10.7%,行业集中度较低。2) 该集团通过并购实现全球扩张:从IPO阶段截至2026年上半年,公司已完成超过15项收购;其中Hexa Ceram在2025年贡献了2.16亿港元收入(约占集团收入增长的60%)。3) 数字化渗透使订单集中释放利润弹性:该集团2025年数字化病例占比约35%–40%;亚洲生产基地处理的数字化病例数量从2023年的58.1万例增至2025年的103.9万例(复合年增长率约33.7%),同时员工成本占比由48.0%降至43.6%,预期公司数字化有望推动利润继续快于收入增长。
  3. FinanceChangzhou Microintelligence Co., Ltd passes HKEX Listing Committee hearingHong Kong, Oct 12, 2026 - Changzhou Microintelligence Co., Ltd (“Microintelligence” or “the Company”) recently passed the hearing of the Listing Committee of The Stock Exchange of Hong Kong Limited (HKEX) on X 2026. Orient Capital, the subsidiary of Orient Securities, is the sole sponsor for the initial public offering. Based on 2025 revenue, the Company is China’s largest supplier of Embodied Industrial Intelligent Robots (EIIR), with a market share of approximately 20.0%. Microintelligence was founded in 2018. As a leader in industrial embodied intelligence, the Company develops EIIR products and integrated solutions capable of autonomous perception, learning, decision-making and executing of complex tasks with its full-stack self-developed software, hardware and systems engineering capabilities. Its products have achieved commercialization at scale in real-world industrial settings, including in industries with extremely high requirements for precision, stability, and reliability, such as 3C electronics, automotive manufacturing, new energy, fast-moving consumer goods (FMCG), and semiconductors. Meanwhile, its application scenarios are evolving from "mature single-process workflow” to "integrated workstations." According to IDC's China Industrial Embodied Intelligent Robots Market Share, 2025 report, the company holds the No. 1 market share in China. The Company is also one of the world’s first leading companies to achieve commercial verification of embodied industrial intelligence robots in multiple complex industrial scenarios. Through a standardized "Cloud-Edge-Device" integrated architecture, Microintelligence combines AI models, industrial know-how, and real-world scenario data to build core physical AI capabilities. This enables EIIR to complete a fully autonomous closed loop spanning perception, learning, decision-making, and execution. As EIIR systems roll out across real factory environments, the company has also built a "data-model-product-redeployment" flywheel. On-site data accumulated during production line operations is distilled into process knowledge through a "human-in-the-loop" mechanism with insights fed back into ongoing model iteration. As model capabilities advance, the products can take on more complex production tasks and continue to broaden their application scope. Backed by full-stack software and hardware capabilities and commercial validation in real-world scenarios, the company has delivered efficient, cost-effective commercialisation across multiple industrial scenarios, creating a durable competitive moat. Through the continuous deployment of the aforementioned technologies and industrial practices, the Company has been accumulating real production-line industrial data while maintaining high levels of R&D investment. According to the documents disclosed after its hearing, the Company amassed an unstructured, finely-annotated database sourced from real industrial scenarios, with a data volume exceeding 23TB and containing over 1.6 billion annotated data records. The database holds more than 800 independent intellectual property rights, including over 210 invention patents and 310 software copyrights. In 2024, the Company’s R&D project entitled “Development and Application of High-Speed, Self-Planning, Integrated Intelligent System for Defect Detection and Repair” has been jointly certified by the Ministry of Industry and Information Technology (MIIT) and the Ministry of Science and Technology (MOST) as having reached an “International Leading” level. The Company’s client base includes more than 25 Fortune Global 500 enterprises and leading manufacturers. Its business spans mainland China, Europe and the United States, and actively develops for the expansion into new overseas markets including Japan, Singapore and Malaysia. Financially, the Company’s revenue rose from RMB 434 million in 2023 to RMB 796 million in 2025, representing a compound annual growth rate (CAGR) of 35.4%. For the five months ended May 31, 2026, the Company recorded revenue of RMB 424 million, up 22.6% year on year. Revenue from its flagship EIIR products grew from RMB 114 million in 2023 to RMB 453 million in 2025, and reached RMB 260 million for the five months ended May 31, 2026. The EIIR products’ contribution to total revenue rose to 61.4% for the five months ended May 31, 2026, while gross margin further improved to 54.8%. In terms of profitability, the Company achieved profitable results for two consecutive years in 2024 and 2025. It recorded a full-year profit of approximately RMB 15.7 million in 2024 and approximately RMB 5.1 million in 2025, as higher R&D investment weighed on profit for the year. For the five months ended May 31, 2026, profit reached RMB 22.53 million, while adjusted net profit for the period—excluding the impact of share-based payments and listing expenses—amounted to RMB 33.84 million, up 41.5% year on year. In addition, following the turnaround to positive operating cash flow in 2025, the Company continued to record net cash inflow for the five months ended May 31, 2026, reflecting a substantive and sustained improvement in the cash-generating capability of its core business. The Company plans to primarily allocate the proceeds from this initial public offering to core technology R&D, focusing on iterating the Company’s end-to-end industrial VLA model, to continuously enhance the intelligence and performance of EIIR robots. In parallel, the Company will build localised overseas sales and service networks to deepenits global business footprint. In addition, the Company will allocate the proceeds for strategic investments and to foster an open, win-win application ecosystem through M&A, to expand manufacturing capacity to meet the growing order volumes. Looking ahead, Microintelligence will seize the opportunity presented by its HKEX listing to continue to strengthen its core capabilities in industrial embodied intelligence. As the global manufacturing sector continues to advance its intelligent transformation, the Company will focus on six key dimensions—deepening customer engagement, replicating success across new industries, expanding overseas, upgrading product value, strengthening software-hardware synergies, and driving continuous AI evolution—to bring EIIR solutions into more industrial scenarios. Together with industry partners, the Company will build an industrial embodied intelligence ecosystem and create long-term value for customers and the industry as a whole.
  4. Finance中金首予現代牙科(03600.HK)“跑贏行業”評級 目標價10.0港元:數字化賦能效率提升 加速全球擴張香港, 2026年10月12日 - 中金首予現代牙科集團(03600.HK)“跑贏行業”評級,目標價10.00港元,並指出三大關鍵驅動因素:1) 數字化驅動行業整合:口內掃描技術支援標準化病例可跨區域集中處理,從而提高周轉速度與效率;2025年全球義齒加工市場規模約為243億美元,且CR3(行業前三名市場份額)僅為10.7%,行業集中度較低。2) 該集團通過併購實現全球擴張:從IPO階段截至2026年上半年,公司已完成超過15項收購;其中Hexa Ceram在2025年貢獻了2.16億港元收入(約佔集團收入增長的60%)。3) 數字化滲透使訂單集中釋放利潤彈性:該集團2025年數字化病例佔比約35%–40%;亞洲生產基地處理的數字化病例數量從2023年的58.1萬例增至2025年的103.9萬例(複合年增長率約33.7%),同時員工成本佔比由48.0%降至43.6%,預期公司數字化有望推動利潤繼續快於收入增長。
  5. Finance中金首予現代牙科(03600.HK)“跑贏行業”評級 目標價10.0港元:數字化賦能效率提升 加速全球擴張香港, 2026年10月12日 - 中金首予現代牙科集團(03600.HK)“跑贏行業”評級,目標價10.00港元,並指出三大關鍵驅動因素:1) 數字化驅動行業整合:口內掃描技術支援標準化病例可跨區域集中處理,從而提高周轉速度與效率;2025年全球義齒加工市場規模約為243億美元,且CR3(行業前三名市場份額)僅為10.7%,行業集中度較低。2) 該集團通過併購實現全球擴張:從IPO階段截至2026年上半年,公司已完成超過15項收購;其中Hexa Ceram在2025年貢獻了2.16億港元收入(約佔集團收入增長的60%)。3) 數字化滲透使訂單集中釋放利潤彈性:該集團2025年數字化病例佔比約35%–40%;亞洲生產基地處理的數字化病例數量從2023年的58.1萬例增至2025年的103.9萬例(複合年增長率約33.7%),同時員工成本佔比由48.0%降至43.6%,預期公司數字化有望推動利潤繼續快於收入增長。 中金進一步指出,口內掃描技術的普及使得更多病例可在當地採集,隨後傳輸至亞洲生產基地進行集中設計與生產,為現代牙科集團業務的效率提升開闢了新空間。中金認為未來存在多重催化劑:數字化病例量增長超預期;歐美及東南亞市場需求復蘇超預期;以及併購整合效果良好且產能利用率提升。中金預測該集團2026年和2027年的每股收益(EPS)分別為0.83港元和1.07港元,對應2025年至2027年預測期的複合年增長率為29.3%。按當前股價計算,該股對應的2026年及2027年預期市盈率(P/E)分別為9.6倍和7.4倍;首次覆蓋給予“跑贏行業”評級及10.0港元的目標價(基於2027年預期市盈率9.3倍),較當前股價有約25.5%的上漲空間。 免責聲明:本文提及的觀點摘錄自相關研究報告。有關詳細資訊,請參閱完整報告。
  6. Finance中金首予现代牙科(03600.HK)“跑赢行业”评级 目标价10.0港元:数字化赋能效率提升 加速全球扩张香港, 2026年10月12日 - (亚太商讯) - 中金首予现代牙科集团(03600.HK)“跑赢行业”评级,目标价10.00港元,并指出三大关键驱动因素:1) 数字化驱动行业整合:口内扫描技术支援标准化病例可跨区域集中处理,从而提高周转速度与效率;2025年全球义齿加工市场规模约为243亿美元,且CR3(行业前三名市场份额)仅为10.7%,行业集中度较低。2) 该集团通过并购实现全球扩张:从IPO阶段截至2026年上半年,公司已完成超过15项收购;其中Hexa Ceram在2025年贡献了2.16亿港元收入(约占集团收入增长的60%)。3) 数字化渗透使订单集中释放利润弹性:该集团2025年数字化病例占比约35%–40%;亚洲生产基地处理的数字化病例数量从2023年的58.1万例增至2025年的103.9万例(复合年增长率约33.7%),同时员工成本占比由48.0%降至43.6%,预期公司数字化有望推动利润继续快于收入增长。 中金进一步指出,口内扫描技术的普及使得更多病例可在当地采集,随后传输至亚洲生产基地进行集中设计与生产,为现代牙科集团业务的效率提升开辟了新空间。中金认为未来存在多重催化剂:数字化病例量增长超预期;欧美及东南亚市场需求复苏超预期;以及并购整合效果良好且产能利用率提升。中金预测该集团2026年和2027年的每股收益(EPS)分别为0.83港元和1.07港元,对应2025年至2027年预测期的复合年增长率为29.3%。按当前股价计算,该股对应的2026年及2027年预期市盈率(P/E)分别为9.6倍和7.4倍;首次覆盖给予“跑赢行业”评级及10.0港元的目标价(基于2027年预期市盈率9.3倍),较当前股价有约25.5%的上涨空间。 免责声明:本文提及的观点摘录自相关研究报告。有关详细信息,请参阅完整报告。 Copyright 2026 亚太商讯. All rights reserved. www.acnnewswire.com
  7. FinanceCICC Initiates Coverage of Modern Dental Group (03600.HK) with Outperform Rating and Target Price of HK$10.0: Accelerating Global Expansion with Digital EfficiencyHong Kong, Oct 12, 2026 - CICC initiates coverage on Modern Dental Group (03600.HK) with an “Outperform” rating and a target price of HK$10.00, highlighting three key drivers. 1) Digitalization-led consolidation: intraoral scanning enables standardized cases to be processed centrally, supporting faster turnover and efficiency; the global market scale for dental prosthetics was ~US$24.3bn in 2025 with a low CR3 of 10.7%. 2) Global expansion through M&A: From IPO stage to 1H26, the company completed 15+ acquisitions, and Hexa Ceram contributed HK$216m revenue in 2025 (c. 60% of Group revenue growth). 3) Profit upside unlocked by centralized order and digital penetration: digital cases were ~35%–40% of volume in 2025, while digital cases processed at Asian production bases grew from 581k (2023) to 1.039m (2025) (CAGR ~33.7%) alongside a decline in staff cost ratio (48.0% to 43.6%), digital transformation is expected to drive profit growth ahead of revenue. CICC further notes that the rising penetration of intraoral scanning enables more cases to be captured locally, then transferred to Asian production bases for centralized design and production, creating a new window for efficiency gains in Modern Dental Group. CICC believes that there are multiple catalysts ahead: digital case volume growth beyond expectations, demand recovery in Europe, the US, and Southeast Asia exceeding expectations, and better-than-expected M&A integration alongside improved capacity utilization. CICC projects EPS of HK$0.83 (2026) and HK$1.07 (2027), implying a 29.3% CAGR for 2025–2027E. The current share price implies P/E of 9.6x (2026E) and 7.4x (2027E). CICC initiates an “Outperform” rating for the company with a target price of HK$10.0, based on a 2027E P/E of 9.3x, implying ~25.5% upside. Disclaimer: The views given in this article are extracted from relevant research report. For detailed information, please refer to the full report.
  8. FinanceThe Rosen Law Firm PAROSEN, A RANKED AND LEADING LAW FIRM, Encourages Honeywell Aerospace Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HONAWHY: Rosen Law Firm, a global investor rights law firm, reminds open market purchasers of common stock of Honeywell Aerospace Inc. (NASDAQ: HONA) between June 29, 2026 and September 1, 2026, both dates inclusive (the "Class Period"), of the important November 23, 2026 lead plaintiff deadline.SO WHAT: If you purchased Honeywell Aerospace common stock on the open market during the Class Period you may be entitled to compensation without...
  9. FinanceThe Rosen Law Firm PAROSEN, NATIONAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...
  10. FinanceSkyAI Announces Intention to Commence Cash Tender Offer to Purchase Common Stock and Pre-funded Warrants at $3.00 Per Share/Pre-funded WarrantSkyAI intends to purchase up to 95% of each class of its outstanding common stock, cash pre-funded warrants, cryptocurrency pre-funded warrants and strategic advisor warrants
  11. FinanceThe Rosen Law Firm PAROSEN, NATIONAL INVESTOR COUNSEL, Encourages Papa John's International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PZZAWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Papa John's International, Inc. (NASDAQ: PZZA) between August 7, 2025 and August 5, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Papa Johns common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or...
  12. FinanceSticker MuleNew Independent Economic Study: Sticker Mule Has Generated $2.7 Billion in Economic Impact for New York State and Supported 9,500 JobsEpsilon Economics, the firm behind economic impact studies of the Super Bowl, the Oscars, and the FIFA World Cup, finds the Amsterdam-based manufacturer has paid $681.5 million in wages and generated $49.5 million in state tax revenue since 2016 AMSTERDAM, N.Y., Oct. 11, 2026...